Intco Medical Technology Co., Ltd. (SHE:300677)
China
· Delayed Price · Currency is CNY 56.96
-0.32 (-0.56%)
Apr 29, 2026, 10:45 AM CST
Intco Medical Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 10,253 | 9,860 | 9,436 | 6,887 | 6,591 | 16,217 | Upgrade
|
| Other Revenue | 66.26 | 66.26 | 87.33 | 31.36 | 23.21 | 23.28 | Upgrade
|
| Revenue | 10,319 | 9,926 | 9,523 | 6,919 | 6,614 | 16,240 | Upgrade
|
| Revenue Growth (YoY) | 5.14% | 4.23% | 37.65% | 4.61% | -59.27% | 17.37% | Upgrade
|
| Cost of Revenue | 7,781 | 7,552 | 7,347 | 5,976 | 5,776 | 6,267 | Upgrade
|
| Gross Profit | 2,538 | 2,374 | 2,176 | 942.35 | 837.65 | 9,973 | Upgrade
|
| Selling, General & Admin | 994.84 | 984.19 | 806.58 | 738.31 | 614.49 | 929.36 | Upgrade
|
| Research & Development | 399.39 | 404.38 | 398.34 | 283.37 | 252.32 | 365.22 | Upgrade
|
| Other Operating Expenses | 94.47 | 75 | 45.36 | 67.29 | 55.39 | 44.07 | Upgrade
|
| Operating Expenses | 1,492 | 1,465 | 1,274 | 1,105 | 907.94 | 1,390 | Upgrade
|
| Operating Income | 1,046 | 909 | 901.75 | -162.49 | -70.28 | 8,583 | Upgrade
|
| Interest Expense | -370.14 | -369.15 | -308.04 | -127.74 | -28.46 | -17.61 | Upgrade
|
| Interest & Investment Income | 676.32 | 747.65 | 596.53 | 396.16 | 193.48 | 172.61 | Upgrade
|
| Currency Exchange Gain (Loss) | -401.18 | -401.18 | 225.49 | 133.39 | 548.96 | -103.86 | Upgrade
|
| Other Non Operating Income (Expenses) | -131.57 | -6.78 | -23.13 | -16.42 | -8.61 | -10.45 | Upgrade
|
| EBT Excluding Unusual Items | 819.85 | 879.54 | 1,393 | 222.9 | 635.09 | 8,624 | Upgrade
|
| Gain (Loss) on Sale of Investments | -11.29 | 318.5 | 279.77 | 175.57 | 59.67 | 32.66 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.32 | -0.4 | 0.22 | 0.21 | 2.37 | 0.38 | Upgrade
|
| Asset Writedown | 42.11 | 3.18 | -88.8 | -21.32 | -26.87 | -29.04 | Upgrade
|
| Other Unusual Items | 28.92 | 28.92 | 25.13 | 65.46 | 34.15 | 21.07 | Upgrade
|
| Pretax Income | 879.26 | 1,230 | 1,609 | 442.82 | 704.41 | 8,649 | Upgrade
|
| Income Tax Expense | 182.86 | 182.55 | 117.23 | 54.75 | 65.07 | 1,185 | Upgrade
|
| Earnings From Continuing Operations | 696.41 | 1,047 | 1,492 | 388.06 | 639.34 | 7,463 | Upgrade
|
| Minority Interest in Earnings | -28.4 | -36.49 | -26.21 | -5.07 | -10.27 | -33.4 | Upgrade
|
| Net Income | 668.01 | 1,011 | 1,465 | 383 | 629.07 | 7,430 | Upgrade
|
| Net Income to Common | 668.01 | 1,011 | 1,465 | 383 | 629.07 | 7,430 | Upgrade
|
| Net Income Growth | -57.72% | -31.03% | 282.63% | -39.12% | -91.53% | 6.04% | Upgrade
|
| Shares Outstanding (Basic) | 605 | 640 | 648 | 660 | 662 | 656 | Upgrade
|
| Shares Outstanding (Diluted) | 609 | 644 | 648 | 660 | 662 | 675 | Upgrade
|
| Shares Change (YoY) | -5.37% | -0.72% | -1.80% | -0.28% | -1.97% | 9.01% | Upgrade
|
| EPS (Basic) | 1.10 | 1.58 | 2.26 | 0.58 | 0.95 | 11.33 | Upgrade
|
| EPS (Diluted) | 1.10 | 1.57 | 2.26 | 0.58 | 0.95 | 11.00 | Upgrade
|
| EPS Growth | -55.32% | -30.53% | 289.65% | -38.95% | -91.36% | -2.73% | Upgrade
|
| Free Cash Flow | -617.19 | -689.72 | -710.37 | -936.28 | -649.76 | 3,236 | Upgrade
|
| Free Cash Flow Per Share | -1.01 | -1.07 | -1.10 | -1.42 | -0.98 | 4.79 | Upgrade
|
| Dividend Per Share | 0.150 | 0.150 | 0.150 | 0.080 | 0.099 | 0.625 | Upgrade
|
| Dividend Growth | - | - | 87.50% | -19.00% | -84.20% | -66.25% | Upgrade
|
| Gross Margin | 24.60% | 23.91% | 22.85% | 13.62% | 12.67% | 61.41% | Upgrade
|
| Operating Margin | 10.14% | 9.16% | 9.47% | -2.35% | -1.06% | 52.85% | Upgrade
|
| Profit Margin | 6.47% | 10.18% | 15.39% | 5.54% | 9.51% | 45.75% | Upgrade
|
| Free Cash Flow Margin | -5.98% | -6.95% | -7.46% | -13.53% | -9.82% | 19.93% | Upgrade
|
| EBITDA | 2,036 | 1,873 | 1,761 | 557.08 | 556.79 | 8,950 | Upgrade
|
| EBITDA Margin | 19.73% | 18.87% | 18.50% | 8.05% | 8.42% | 55.11% | Upgrade
|
| D&A For EBITDA | 989.94 | 963.9 | 859.74 | 719.57 | 627.08 | 367.24 | Upgrade
|
| EBIT | 1,046 | 909 | 901.75 | -162.49 | -70.28 | 8,583 | Upgrade
|
| EBIT Margin | 10.14% | 9.16% | 9.47% | -2.35% | -1.06% | 52.85% | Upgrade
|
| Effective Tax Rate | 20.80% | 14.85% | 7.29% | 12.37% | 9.24% | 13.70% | Upgrade
|
| Revenue as Reported | 10,319 | 9,926 | 9,523 | 6,919 | 6,614 | 16,240 | Upgrade
|
| Advertising Expenses | - | 18.77 | 18.92 | 32.98 | 17.85 | 91.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.